Voluntary Recall of One Lot of Gardasil HPV Vaccine - Media Statement
On December 16, 2013 CDC was informed by Merck that the company planned to implement a voluntary recall of one lot (lot J007354) of Gardasil® [Human Papillomavirus Quadrivalent (types 6, 11, 16, and 18) Vaccine, Recombinant], due to the potential for a small number of vials to contain glass particles as a result of breakage during the manufacturing process. These vials were distributed between August 20, 2013, and October 9, 2013. No other lots are affected.
On December 16, 2013 CDC was informed by Merck that the company planned to implement a voluntary recall of one lot (lot J007354) of Gardasil® [Human Papillomavirus Quadrivalent (types 6, 11, 16, and 18) Vaccine, Recombinant], due to the potential for a small number of vials to contain glass particles as a result of breakage during the manufacturing process. These vials were distributed between August 20, 2013, and October 9, 2013. No other lots are affected.
This Coalition transmission preserves metadata, trust context, and source routing for a Public Intelligence item from CDC. The complete article remains with the original publisher.
Content handling is marked as Public Domain. Use the source article link for the full report, updates, corrections, and publisher-controlled context.
Key Points
- Published by CDC.
- Categorized as Public Intelligence.
- Source handling: Verified Source.
- Rights posture: Public Domain.
- Follow the source article for the complete original report.